Thu, Jul 31, 2014, 10:30 PM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

Vical Incorporated Message Board

  • johnodod johnodod Oct 22, 2013 2:40 PM Flag

    AnGes News Release

    AnGes has a news release on the Japanese language site announcing near-term rollout of the Collategene Phase 3. They indicate the market size of this opportunity if successful is $50 billion. It would be nice to here something about this from Vijay on the quarterly report conference call. Poor AnGes had to put out two releases on Vical's failure, including one saying they aren't going out of business because A-7 didn't make it.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Actually from the Vical web site:
      AnGes has applied Vical's technologies to the local delivery of a gene that encodes an angiogenic growth factor that promotes the growth of blood vessels. AnGes announced that it had reached agreement with the FDA regarding a Special Protocol Assessment for a Phase 3 clinical trial of its Collategene™ angiogenesis product and that the FDA has granted “Fast Track” designation to Collategene™ as a treatment for critical limb ischemia. AnGes is currently preparing for a global Phase 3 clinical trial of Collategene™ in patients with advanced PAD. AnGes believes having Japanese sites participate in the global Phase 3 trial represents the best potential pathway to approval in Japan, and has withdrawn its New Drug Application (NDA) previously submitted to the Japanese Ministry of Health, Labor and Welfare.

      I am dubious of the $50B number. I suspect potential sales much much lower.

      Sentiment: Hold

    • kronykapitalist@ymail.com kronykapitalist Oct 22, 2013 9:44 PM Flag

      VJ is at the beach

      Sentiment: Hold

 
VICL
1.310.00(0.00%)Jul 31 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Tesla Motors, Inc.
NasdaqGSThu, Jul 31, 2014 4:00 PM EDT
Expedia Inc.
NasdaqGSThu, Jul 31, 2014 4:00 PM EDT